| Gene symbol | KIT | Synonyms | C-Kit, CD117, MASTC, PBT, SCFR | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4q12 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | KIT proto-oncogene, receptor tyrosine kinase | ||||
| Gene symbol | PROM1 | Synonyms | AC133, CD133, CORD12, MCDR2, MSTP061, PROML1, RP41, STGD4 | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4p15.32 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | prominin 1 | ||||
| Gene symbol | MUC1 | Synonyms | ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q22 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mucin 1, cell surface associated | ||||
| GTO ID | GTC1822 |
| Trial ID | NCT03356782 |
| Disease | Sarcoma | Osteosarcoma | Ewing Sarcoma |
| Altered gene | CD133|GD2|MUC1|CD117 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD133/GD2/Muc1/CD117 CAR-T cells |
| Generation | 4th |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas |
| Year | 2017 |
| Country | China |
| Company sponsor | Shenzhen Geno-Immune Medical Institute |
| Other ID(s) | GIMI-IRB-17016 |
| Cohort 1 | |||||||||
|
|||||||||